Radforsk Investeringsstiftelse Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 17

  • Portfolio
  • 7

  • Exits
  • 8

Exits

Radforsk Investeringsstiftelse General Information

Company Description

Founded in 1986, Radforsk Investeringsstiftelse is a venture capital firm based in Oslo, Norway. The firm prefers to invest in oncology, novel therapeutics, diagnostics, and immuno-oncology sectors.

Business Details

Formerly Known As
The Norwegian Radium Hospital Research Foundation
Year Founded
1986
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Ullernchausseen 64
  • 0379 Oslo
  • Norway

Radforsk Investeringsstiftelse Investments (17)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ARTBIO 21-Jun-2023 Seed Round Biotechnology Pre-Clinical Trials
Hubro Therapeutics 01-Jul-2021 Drug Discovery Bankruptcy: Liquidation
Oncoinvent 29-Jun-2021 Drug Discovery Generating Revenue/Not Profitable
AdjuTec Pharma 01-Jan-2021 Drug Discovery Pre-Clinical Trials
Nordic Nanovector 23-Sep-2020 Biotechnology Generating Revenue
Ledidi 31-Aug-2020 Business/Productivity Software Generating Revenue
Photocure 25-Jun-2020 Pharmaceuticals Profitable
Hubro Therapeutics 30-Jun-2019 Drug Discovery Bankruptcy: Liquidation
NEC OncoImmunity 06-Apr-2017 Grant Discovery Tools (Healthcare) Generating Revenue
Zelluna Immunotherapy 01-Jan-2016 Early Stage VC Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 17 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Radforsk Investeringsstiftelse Exits (8)

Company Name Exit Date Exit Type Exit Size
Zelluna Immunotherapy 17-Dec-2024 Reverse Merger
Oncoinvent 13-Dec-2024
Hubro Therapeutics 07-Mar-2024
Nordic Nanovector 03-Jul-2023
Nykode 07-Oct-2020
NEC OncoImmunity 29-Jul-2019 Merger/Acquisition
Circio 16-Jun-2014 IPO
You’re viewing 7 of 8 exits. Get the full list »

Radforsk Investeringsstiftelse Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Radforsk Investeringsstiftelse Co-Investors (11)

Name With Exits Lead Partner Series Industry
Algot Invest 1 Series chart Industry bar
Canica Series chart Industry bar
Investinor Series chart Industry bar
Omega Funds Series chart Industry bar
Timmuno Series chart Industry bar
You’re viewing 5 of 11 co-investors. Get the full list »

Radforsk Investeringsstiftelse FAQs

  • What is Radforsk Investeringsstiftelse?

    Founded in 1986, Radforsk Investeringsstiftelse is a venture capital firm based in Oslo, Norway.

  • When was Radforsk Investeringsstiftelse founded?

    Radforsk Investeringsstiftelse was founded in 1986.

  • Where is Radforsk Investeringsstiftelse headquartered?

    Radforsk Investeringsstiftelse is headquartered in Oslo, Norway.

  • How many investments has Radforsk Investeringsstiftelse made?

    Radforsk Investeringsstiftelse has made 17 investments.

  • What has Radforsk Investeringsstiftelse invested in?

    Radforsk Investeringsstiftelse has made numerous investments in companies like ARTBIO, Hubro Therapeutics, and Oncoinvent within the Biotechnology and Drug Discovery industries.

  • What has Radforsk Investeringsstiftelse invested in recently?

    Radforsk Investeringsstiftelse's latest investment was on 21-Jun-2023 in ARTBIO, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »